FDA approves two Tecnis multifocal IOLs from Abbott

The U.S. Food and Drug Administration approved Abbott’s +2.75 D and +3.25 D Tecnis one-piece multifocal IOLs, according to a press release.The new IOLs provide cataract patients with options to have a full range of near, intermediate and distance vision, with a treatment customized to meet their personal needs and lifestyle, the release said.